drugset / Trial / NCT02153541

Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults

NCT02153541 ↗

Phase 2 Unknown 50 enrolled Global United Pharmaceutical Corporation
RandomizedSingle-groupTriple-blindTreatment

Summary

This is a double-blind, randomized, placebo-controlled, proof of concept, study in adults with poorly controlled moderate to severe asthma. The researchers believe that by using a local anesthetic to block a certain nerve in the ear, it will improve all aspects of asthma, such as decreasing the numbers of times patients have to use a rescue inhaler, and improving asthma treatment assessment questionnaire scores, with no bad changes to lung function and inflammation.

Timeline

Start
2023-04-01
Primary completion
2023-08-01
Completion
2023-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Antipyrine-benzocaine Unknown — Topical

Indications